vs
M/I HOMES, INC.（MHO）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
M/I HOMES, INC.的季度营收约是Royalty Pharma plc的1.8倍（$1.1B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 5.6%，领先28.9%），Royalty Pharma plc同比增速更快（4.8% vs -4.8%），过去两年M/I HOMES, INC.的营收复合增速更高（4.7% vs 4.6%）
M/I Homes是美国领先的住宅建筑企业，主要设计、建造及销售独栋住宅、联排住宅与复式公寓，业务覆盖美国多州，面向首次置业、改善型及高端置业群体，提供节能住宅产品与个性化定制服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MHO vs RPRX — 直观对比
营收规模更大
MHO
是对方的1.8倍
$622.0M
营收增速更快
RPRX
高出9.6%
-4.8%
净利率更高
RPRX
高出28.9%
5.6%
两年增速更快
MHO
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $64.0M | $214.2M |
| 毛利率 | 17.4% | — |
| 营业利润率 | 6.5% | 62.4% |
| 净利率 | 5.6% | 34.4% |
| 营收同比 | -4.8% | 4.8% |
| 净利润同比 | -52.1% | 2.9% |
| 每股收益（稀释后） | $2.42 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MHORPRX
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $976.1M | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.0B | $568.0M |
净利润MHORPRX
| Q4 25 | $64.0M | $214.2M | ||
| Q3 25 | $106.5M | $288.2M | ||
| Q2 25 | $121.2M | $30.2M | ||
| Q1 25 | $111.2M | $238.3M | ||
| Q4 24 | $133.5M | $208.2M | ||
| Q3 24 | $145.4M | $544.0M | ||
| Q2 24 | $146.7M | $102.0M | ||
| Q1 24 | $138.1M | $4.8M |
毛利率MHORPRX
| Q4 25 | 17.4% | — | ||
| Q3 25 | 24.5% | — | ||
| Q2 25 | 24.7% | — | ||
| Q1 25 | 25.9% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 27.9% | — | ||
| Q1 24 | 27.1% | — |
营业利润率MHORPRX
| Q4 25 | 6.5% | 62.4% | ||
| Q3 25 | 12.0% | 70.1% | ||
| Q2 25 | 13.4% | 36.3% | ||
| Q1 25 | 14.4% | 94.0% | ||
| Q4 24 | 13.6% | 60.9% | ||
| Q3 24 | 15.9% | — | ||
| Q2 24 | 16.8% | 50.2% | ||
| Q1 24 | 16.6% | -13.0% |
净利率MHORPRX
| Q4 25 | 5.6% | 34.4% | ||
| Q3 25 | 9.4% | 47.3% | ||
| Q2 25 | 10.4% | 5.2% | ||
| Q1 25 | 11.4% | 41.9% | ||
| Q4 24 | 11.1% | 35.1% | ||
| Q3 24 | 12.7% | 96.3% | ||
| Q2 24 | 13.2% | 19.0% | ||
| Q1 24 | 13.2% | 0.8% |
每股收益（稀释后）MHORPRX
| Q4 25 | $2.42 | $0.49 | ||
| Q3 25 | $3.92 | $0.67 | ||
| Q2 25 | $4.42 | $0.07 | ||
| Q1 25 | $3.98 | $0.55 | ||
| Q4 24 | $4.71 | $0.46 | ||
| Q3 24 | $5.10 | $1.21 | ||
| Q2 24 | $5.12 | $0.23 | ||
| Q1 24 | $4.78 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.2B | $9.7B |
| 总资产 | $4.8B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MHORPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务MHORPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MHORPRX
| Q4 25 | $3.2B | $9.7B | ||
| Q3 25 | $3.1B | $9.6B | ||
| Q2 25 | $3.1B | $9.5B | ||
| Q1 25 | $3.0B | $9.8B | ||
| Q4 24 | $2.9B | $10.3B | ||
| Q3 24 | $2.8B | $10.3B | ||
| Q2 24 | $2.7B | $9.8B | ||
| Q1 24 | $2.6B | $9.9B |
总资产MHORPRX
| Q4 25 | $4.8B | $19.6B | ||
| Q3 25 | $4.8B | $19.3B | ||
| Q2 25 | $4.7B | $18.3B | ||
| Q1 25 | $4.6B | $17.6B | ||
| Q4 24 | $4.5B | $18.2B | ||
| Q3 24 | $4.5B | $18.0B | ||
| Q2 24 | $4.3B | $17.7B | ||
| Q1 24 | $4.2B | $16.1B |
负债/权益比MHORPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-13.0M | — |
| 自由现金流率自由现金流/营收 | -1.1% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | -0.14× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $127.7M | — |
8季度趋势，按日历期对齐
经营现金流MHORPRX
| Q4 25 | $-8.7M | $827.1M | ||
| Q3 25 | $43.4M | $702.6M | ||
| Q2 25 | $37.8M | $364.0M | ||
| Q1 25 | $64.9M | $596.1M | ||
| Q4 24 | $104.4M | $742.5M | ||
| Q3 24 | $-67.9M | $703.6M | ||
| Q2 24 | $27.5M | $658.2M | ||
| Q1 24 | $115.8M | $664.6M |
自由现金流MHORPRX
| Q4 25 | $-13.0M | — | ||
| Q3 25 | $42.0M | — | ||
| Q2 25 | $35.1M | — | ||
| Q1 25 | $63.5M | — | ||
| Q4 24 | $102.3M | — | ||
| Q3 24 | $-68.5M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $115.5M | — |
自由现金流率MHORPRX
| Q4 25 | -1.1% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | -6.0% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | 11.0% | — |
资本支出强度MHORPRX
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.0% | — |
现金转化率MHORPRX
| Q4 25 | -0.14× | 3.86× | ||
| Q3 25 | 0.41× | 2.44× | ||
| Q2 25 | 0.31× | 12.06× | ||
| Q1 25 | 0.58× | 2.50× | ||
| Q4 24 | 0.78× | 3.57× | ||
| Q3 24 | -0.47× | 1.29× | ||
| Q2 24 | 0.19× | 6.45× | ||
| Q1 24 | 0.84× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MHO
| Southern Homebuilding | $615.6M | 54% |
| Northern Homebuilding | $503.9M | 44% |
| Financial Service | $27.8M | 2% |
| Land | $4.7M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
